To investigate the observation suggesting that the BTK C481S mutation could confer a cross resistance to PI3K inhibitors further, we overexpressed BTKWT or BTKC481S in a human diffuse large B-cell lymphoma cell line sensitive to ibrutinib (TMD8). The gene discussed is BTK; the disease is diffuse large B-cell lymphoma.